Name | Traded | Action | Notifier | Last | Amount | Value |
---|---|---|---|---|---|---|
Indivior | 17-Mar-25 | Transfer From | Mark Crossley | n/a | 9,974 | n/a |
Haleon | 14-Mar-25 | Transfer From | Brian McNamara | n/a | 1,604,522 | n/a |
Haleon | 14-Mar-25 | Sell | Brian McNamara | n/a | 755,258 | n/a |
HUTCHMED (China) Limited | 13-Mar-25 | Transfer From | Weiguo Su | n/a | 19,913 | n/a |
Oxford Nanopore Technologies | 12-Mar-25 | Transfer From | Nick Keher | n/a | 150 | n/a |
Name | Traded | Action | Notifier | Last | Amount | Value |
---|---|---|---|---|---|---|
GSK | 21-Feb-25 | Buy | Hal Barron | 3,664.00p | 3,269,946 | £119,810,819.44 |
GSK | 16-Apr-24 | Buy Dividends | Hal Barron | $39.79 | 2,906,213 | $95,366,062.48 |
GSK | 16-Apr-24 | Buy Dividends | Emma Walmsley | 1,611.28p | 1,840,922 | £29,662,409.10 |
Allergy Therapeutics | 14-Jan-25 | Exercise of option | Zheqing Shen | 4.00p | 457,937,504 | £18,317,499.75 |
Allergy Therapeutics | 14-Jan-25 | Exercise of option | Anthony Parker | 4.00p | 229,562,496 | £9,182,499.63 |